6,11-bridged erythromycin derivatives
US6046171A · kind A · utility
26Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 1998 |
| Grant date | Apr 4, 2000 |
| Priority date | — |
| Expiry date | Sep 22, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.